Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2012
08/15/2012EP2486930A1 Cell preparation for erectile dysfunction or urinary incontinence containing adipose tissue derived mesenchymal stem cells
08/15/2012EP2485729A1 Treatment with cholinergic agonists
08/15/2012EP2276756B9 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012CN102639527A Novel phenylpyridine derivative and medicinal agent comprising same
08/15/2012CN102639518A Novel phenol derivative
08/15/2012CN102639513A Sphingosine kinase inhibitors
08/15/2012CN102634492A Polyethylene glycol dog source urate oxidase analogue, and preparation method and applications thereof
08/15/2012CN102633904A Hydrolysis technology for protease of heparin sodium
08/15/2012CN102633850A Rhoifolin extraction method and usage of drug prepared by rhoifolin
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102631585A Multi-effect Chinese medicinal herbal formula and preparation process thereof
08/15/2012CN102631547A Traditional Chinese medicine for treating diabetic nephropathy
08/15/2012CN102631537A Chinese medicament for treating diabetic nephropathy
08/15/2012CN102631461A Traditional Chinese medicine (TCM) for treating chronic prostatitis
08/15/2012CN102631459A Traditional Chinese medicine for treating chronic prostatitis
08/15/2012CN102631447A Chinese patent medicine for treating gonorrhea and preparation method thereof
08/15/2012CN102631443A Traditional Chinese medicine (TCM) for treating prostatic hyperplasia
08/15/2012CN102631442A Traditional Chinese medicine (TCM) for treating prostatic hyperplasia
08/15/2012CN102631415A Traditional Chinese medicine composite as well as product and application thereof
08/15/2012CN102631395A Rape pollen dispersible tablet for treating prostatitis and preparation method of rape pollen dispersible tablet
08/15/2012CN102631382A Turpinia arguta seen leaf ethanol diacolation extract, preparation method thereof and application
08/15/2012CN102631366A Application of spirulina polysaccharides to preparation of drugs for preventing and treating male reproductive toxicity caused by organophosphorus pesticides (OPs)
08/15/2012CN102631358A Application of polydatin in preparing medicament for treating diabetic nephropathy
08/15/2012CN102631355A Medicine composite containing aspirin and application thereof
08/15/2012CN102631351A Application of oleanolic acid in pharmacy
08/15/2012CN102631326A Sustained release microsphere used for injection and preparation method and applications of sustained release microsphere
08/15/2012CN101973868B Sodium phenylbutyrate crystal I and preparation method thereof
08/15/2012CN101698816B Coix seed wine and coix seed ginseng root wine
08/15/2012CN101495463B Seven-membered ring compound, production method thereof and pharmaceutical use thereof
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/14/2012US8242173 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
08/14/2012US8242117 5-membered heterocycle-based p38 kinase inhibitors
08/14/2012US8242098 Methods of treating hormone-related conditions using thio-oxindole derivatives
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012CA2520628C T-type calcium channel blocker
08/14/2012CA2511509C Benzoazolylpiperazine derivatives having vr1 antagonist activity
08/09/2012WO2012106287A2 Methods of treating acute kidney injury with retinoc acid
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202830 Substituted xanthine derivatives
08/09/2012US20120202825 Soluble Salts of Thieno [2,3-d] Pyrimidine Derivatives
08/09/2012US20120202824 Pyrazines as delta opioid receptor modulators
08/09/2012US20120202819 Combination therapy using a beta 3 adrenergic receptor agonists and an antimuscarinic agent
08/09/2012US20120202811 Novel compounds
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120201894 Pharmaceutical formulations for the treatment of overactive bladder
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120201815 Methods of altering bone growth by administration of sost or wise antagonist or agonist
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/08/2012EP2484681A1 Chemically and chirally pure gentisate salt of solifenacin
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484669A1 Novel phenol derivative
08/08/2012EP2484668A1 Indazole analogue
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484361A1 Agent for reducing visceral fat weight
08/08/2012EP2484352A1 Liquid compositions of calcium acetate
08/08/2012EP2483685A1 Method of calculating a phosphorus-protein ratio
08/08/2012EP2482828A1 Hematopoietic stem cells for use in the treatment of a kidney injury
08/08/2012EP2181990B1 Piperidine derivative
08/08/2012EP2035004B1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/08/2012EP1942881B1 Compositions and methods for treatment of renal failure
08/08/2012CN1921874B Herbal extract for renal disorders
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627613A 2-[(4,6-dimethyl pyrimidine-2-)oxyl]-3-cyano-3,3-dibenzyl propionic acid optical isomer, its preparation method and medical application
08/08/2012CN102627578A Phenyl benzylamine compound and application thereof
08/08/2012CN102626489A Traditional Chinese medicine for treating prostatic hyperplasia
08/08/2012CN102626481A Traditional Chinese medicine for treating chronic prostatitis
08/08/2012CN102626467A Traditional Chinese medicine for treating diabetic nephropathy
08/08/2012CN102626458A Urologic anti-inflammation pill
08/08/2012CN101884641B Method for building animal model for treating chronic renal injury by using traditional Chinese medicine
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236824 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/07/2012US8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
08/07/2012CA2477737C Multi-substituted selective androgen receptor modulators and methods of use thereof
08/02/2012WO2012103415A1 Dosage regimen for the treatment of multiple disorders with botulinum toxins
08/02/2012WO2012102405A1 Ring-fused compound
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012102297A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012WO2012102255A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012WO2012102254A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196867 Composition comprising a pde4 inhibitor and a pde5 inhibitor
08/02/2012US20120196855 Oxygen linked pyrimidine derivatives
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 562